The grant application was likely with regard to the lung cell test. The exciting question is are they proposing phase 2 human trials for the grant money. With these results and Brilicidin's safety profile I wouldn't be surprised if they skip the Rhesus monkeys and go straight into the clinic.
Go IPIX!
(2)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links